BAX69
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAX69, covering 2017-06-15 to 2018-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer [Phase 2]